Patent · US Active

Compositions and methods of cellular immunotherapy

US11596653B2 · kind B2 · utility

0Cited by

2References

29Claims

0Family size

Assignee

CRAGE MEDICAL CO., LIMITED · CN

Inventors

Zonghai LI · Shanghai, CN
Huiping Gao · Shanghai, CN
Peng Wang · Carlsbad, US
Hua Jiang · Shanghai, CN
Huamao WANG · Shanghai, CN

Key dates

Filing date	Oct 19, 2018
Grant date	Mar 7, 2023
Priority date	—
Expiry date	May 7, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/16043
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods of treating a subject exhibiting a solid tumor that expresses Glypican-3 (GPC3). The methods typically utilize g GPC3 chimeric antigen receptor immunoresponsive cells to a subject in need thereof to effect killing of tumor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.